About Robert Engler
Robert Engler is a director at Auxilium Biotechnologies.
Robert Engler first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Engler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Engler works with at each company, as listed on that company's latest Form D.
Auxilium Biotechnologies Inc. · Form D/A, Dec 11, 2025